The survey focuses on access-based pricing of medicinal products. It seeks to gather insights from all stakeholders on the price determinants for new products, and how these can be applied to inform and operationalise the ASCERTAIN Pricing Model.
This model, currently in development, builds on AIM’s Fair Pricing Calculator and is designed as a publicly available tool for payers, HTA bodies, healthcare professionals, industry, and patient representatives. Its goal is to balance patient access, the financial sustainability of health systems, and incentives for innovation.
Survey Details
- Deadline: 18 July 2025
- Duration: 10–15 minutes
- Responses are fully anonymous
- Link: ASCERTAIN | Survey on pricing of medicinal products
Your expertise and perspective as part of the pharmaceutical pricing and reimbursement community are essential to shaping a model that is both practical and impactful.
If you have any questions or wish to receive a PDF version of the questionnaire in advance, feel free to contact the ASCERTAIN Pricing Team: ln.rue.mphse@rednax | ta.geog@rehclaS.nailimixaM | eb.siradilos@xkcirdneh.enna
Thank you for your valuable contribution!